SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-036093
Filing Date
2019-10-01
Accepted
2019-10-01 16:25:41
Documents
14
Period of Report
2019-10-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hrtx-8k_20191001.htm   iXBRL 8-K 37943
2 EX-99.1 hrtx-ex991_6.htm EX-99.1 10320
3 GRAPHIC g3ylcy5c3ywt000001.jpg GRAPHIC 6688
  Complete submission text file 0001564590-19-036093.txt   192250

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA hrtx-20191001.xsd EX-101.SCH 5969
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE hrtx-20191001_lab.xml EX-101.LAB 19498
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hrtx-20191001_pre.xml EX-101.PRE 11632
11 EXTRACTED XBRL INSTANCE DOCUMENT hrtx-8k_20191001_htm.xml XML 3568
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

IRS No.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33221 | Film No.: 191129432
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences